Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Waldencast plc
SIC 2844 · Perfumes, Cosmetics & Other Toilet Preparations
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Waldencast plc
SIC 2844 · Perfumes, Cosmetics & Other Toilet Preparations
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Waldencast plc
SIC 2844 · Perfumes, Cosmetics & Other Toilet Preparations
Notes
Support
about
terms
$
WALD
Waldencast plc
CIK:
0001840199
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.25.4
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]
Net revenue
$ 272,071
$ 273,868
$ 218,138
Cost of goods sold
89,053
82,124
76,561
Gross profit
183,018
191,744
141,577
Selling, general and administrative
247,984
245,297
223,508
Loss on impairment of goodwill
152,018
5,031
0
Gain on sale of trademark
(5,679)
0
0
Loss on acquisition
6,233
0
0
Total operating expenses
400,556
250,328
223,508
Total operating loss
(217,538)
(58,584)
(81,931)
Interest expense, net
25,094
17,155
18,906
Loss on extinguishment of debt
24,398
0
0
Change in fair value of derivative liabilities
(3,695)
(23,627)
10,337
Change in contingent consideration liabilities (Note 10)
(861)
0
0
Other (income) expense, net
(229)
(3,574)
1,769
Total other expenses (income), net
44,707
(10,046)
31,012
Loss before income taxes
(262,245)
(48,538)
(112,943)
Income tax (benefit) expense
(14,189)
110
(6,975)
Net loss
(248,056)
(48,648)
(105,968)
Net loss attributable to noncontrolling interests
(18,307)
(6,205)
(15,987)
Net loss attributable to Class A shareholders
$ (229,749)
$ (42,443)
$ (89,981)
Net loss per share attributable to Class A shareholders (Note 14):
Basic (in dollars per share)
$ (2.01)
$ (0.39)
$ (0.99)
Diluted (in dollars per share)
$ (2.01)
$ (0.39)
$ (0.99)
Shares used in computing net loss per share (Note 14):
Basic (in shares)
114,070,225
109,295,742
91,158,500
Diluted (in shares)
114,070,225
109,295,742
91,158,500
Other comprehensive (loss) income — foreign currency translation adjustments, net of tax
$ (684)
$ 450
$ (147)
Comprehensive loss
(248,740)
(48,198)
(106,115)
Comprehensive loss attributable to noncontrolling interests
(18,357)
(6,148)
(16,012)
Comprehensive loss attributable to Class A shareholders
$ (230,383)
$ (42,050)
$ (90,103)
v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
$ (248,056)
$ (48,648)
$ (105,968)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
11,796
9,392
9,235
Depreciation and amortization
59,184
60,015
60,498
Non-cash lease expense
2,104
1,986
1,721
Paid-in-kind interest expense
2,680
0
0
Provision (recovery) for credit losses
165
(996)
0
Change in fair value of derivative warrant liabilities
(3,839)
(23,627)
10,337
Change in fair value on interest rate collar
0
0
106
Change in fair value of contingent consideration liabilities
(861)
0
0
Change in fair value of embedded derivative
144
0
0
Amortization of debt issuance costs
2,370
1,712
1,575
Amortization and release of related party liability
0
(5,856)
(4,058)
Loss on extinguishment of debt
24,398
0
0
Deferred income taxes
(17,444)
(1,185)
(7,021)
Loss on impairment of goodwill
152,018
5,031
0
Loss on acquisition
6,233
0
0
Gain on sale of trademark
(5,679)
0
0
Loss on impairment of right of use assets
0
0
3,643
Loss on disposal of equipment
0
112
62
Changes in operating assets and liabilities:
Accounts receivable
(2,696)
(3,158)
(2,071)
Related party accounts receivable
263
309
(816)
Inventories
(867)
2,580
(1,300)
Prepaid expenses
318
(2,236)
996
Other current assets and other assets
158
(377)
138
Accounts payable
(6,802)
(2,982)
4,382
Related party accounts payable
0
(18)
(354)
Operating lease liabilities
(3,002)
(2,677)
(2,560)
Other current liabilities and other liabilities
14,599
1,803
1,680
Net cash used in operating activities
(12,816)
(8,820)
(29,775)
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditure on intangible assets
(237)
(304)
(455)
Capital expenditure on property and equipment
(3,430)
(2,708)
(1,591)
Proceeds from sale of trademark
82,500
0
0
Acquisition of Novaestiq
(2,605)
0
0
Cash received from interest rate collar premium
0
92
52
Net cash provided by (used in) investing activities
76,228
(2,920)
(1,994)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from PIPE investments
0
0
70,000
Payment of PIPE transaction costs
0
0
(1,068)
Proceeds from term loan, net of discount
396,063
0
0
Repayment of term loan
(405,343)
(8,750)
(8,777)
Proceeds from revolving credit facility, net of discount
44,325
15,000
35,000
Repayment of revolving credit facility
(60,000)
0
(49,117)
Proceeds from note payable
1,517
1,632
2,420
Repayment of note payable
(1,575)
(1,770)
(1,452)
Payment of debt issuance costs
(10,153)
0
0
Payment of debt termination fees
(11,604)
0
0
RSU taxes paid on behalf of employees
(451)
(530)
(1,473)
Distribution to pay withholding taxes
0
0
(1,204)
Net cash (used in) provided by financing activities
(47,221)
5,582
44,329
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
16,191
(6,158)
12,560
Effect of foreign exchange rates on cash and cash equivalents
(601)
(116)
(147)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH - Beginning of period
16,302
22,576
10,163
CASH, CASH EQUIVALENTS AND RESTRICTED CASH - End of period
31,892
16,302
22,576
SUPPLEMENTAL CASH FLOW DATA – CASH PAID:
Interest
21,425
15,125
17,331
NON-CASH INVESTING AND FINANCING ACTIVITIES:
Non-cash portion of distribution agreement acquired
29,781
0
0
Capital expenditures in accounts payable and accruals
219
146
318
Issuance of stock for acquisition
7,556
0
0
Contingent consideration (Equity classified)
21,881
0
0
Initial measurement of embedded derivatives
12,553
0
0
Accrued but unpaid debt issuance costs
1,000
0
0
Deferred tax liability on acquisition
6,482
0
0
Reconciliation of cash, cash equivalents and restricted cash. The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows:
Cash and cash equivalents
30,379
14,802
21,089
Restricted cash
1,513
1,500
1,487
Total cash, cash equivalents and restricted cash shown in the consolidated statements of cash flows
$ 31,892
$ 16,302
$ 22,576
v3.25.4
CONSOLIDATED BALANCE SHEETS - USD ($)
Dec. 31, 2025
Dec. 31, 2024
CURRENT ASSETS:
Cash and cash equivalents
$ 30,379,000
$ 14,802,000
Restricted cash
1,513,000
1,500,000
Inventories
54,609,000
53,104,000
Prepaid expenses
6,397,000
7,513,000
Other current assets
4,811,000
427,000
Total current assets
126,943,000
103,622,000
Property and equipment, net
6,240,000
5,831,000
Intangible assets, net
427,098,000
526,438,000
Goodwill
177,571,000
329,589,000
Right-of-use asset, net
7,735,000
9,839,000
Other non-current assets
574,000
541,000
TOTAL ASSETS
746,161,000
975,860,000
CURRENT LIABILITIES:
Current portion of operating lease liabilities
2,111,000
2,766,000
Current portion of long-term debt
771,000
29,479,000
Embedded derivative liabilities
11,833,000
0
Other current liabilities
40,367,000
19,560,000
Total current liabilities
74,547,000
76,892,000
Long-term debt, net
135,752,000
137,137,000
Derivative warrant liabilities
1,181,000
5,021,000
Long-term operating lease liabilities
10,377,000
12,724,000
Deferred income tax liabilities
3,082,000
14,044,000
Contingent consideration liabilities
21,020,000
0
Other non-current liabilities
104,000
105,000
TOTAL LIABILITIES
246,063,000
245,923,000
COMMITMENTS AND CONTINGENCIES (Note 17)
SHAREHOLDERS’ EQUITY:
Preferred shares, 25,000,000 shares authorized, $0.0001 par value, none issued and outstanding
0
0
Additional paid-in capital
981,197,000
951,260,000
Accumulated deficit
(518,953,000)
(289,204,000)
Accumulated other comprehensive (loss) income
(378,000)
251,000
TOTAL CONTROLLING SHAREHOLDERS’ EQUITY
461,879,000
662,319,000
Noncontrolling interest
38,219,000
67,618,000
TOTAL SHAREHOLDERS' EQUITY
500,098,000
729,937,000
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
746,161,000
975,860,000
Nonrelated Party
CURRENT ASSETS:
Accounts receivable, net
28,014,000
25,484,000
CURRENT LIABILITIES:
Accounts payable
19,465,000
25,087,000
Related Party
CURRENT ASSETS:
Accounts receivable, net
1,220,000
792,000
Class A Ordinary Shares
SHAREHOLDERS’ EQUITY:
Ordinary shares
12,000
11,000
Class B Ordinary Shares
SHAREHOLDERS’ EQUITY:
Ordinary shares
$ 1,000
$ 1,000